Patterns of Emphysema Heterogeneity
暂无分享,去创建一个
P. Raffy | J. Tschirren | F. Herth | R. Eberhardt | A. Valipour | C. Strange | W. Gesierich | P. Shah | G. Snell | Robert Barry | Avina Gupta | Erik Henne | Sourish Bandyopadhyay | Youbing Yin | Juerg Tschirren
[1] A. Gulsvik,et al. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. , 1991, Thorax.
[2] J. Verschakelen,et al. Measurement of lung density by means of quantitative CT scanning. A study of correlations with pulmonary function tests. , 1992 .
[3] U Stammberger,et al. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. , 1997, The Annals of thoracic surgery.
[4] H A Vrooman,et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.
[5] P. Gevenois,et al. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. , 2001, The European respiratory journal.
[6] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[7] G. Snell,et al. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema , 2006, Thorax.
[8] P. Laveneziana,et al. Physiology and consequences of lung hyperinflation in COPD , 2006, European Respiratory Review.
[9] D. Mannino,et al. Global burden of COPD: risk factors, prevalence, and future trends , 2007, The Lancet.
[10] F. Herth,et al. Endoscopic Lung Volume Reduction , 2009, Respiration.
[11] R. Zuwallack,et al. Patient-reported dyspnea in COPD reliability and association with stage of disease. , 2009, Chest.
[12] H. Magnussen,et al. Physical activity in patients with COPD , 2008, European Respiratory Journal.
[13] Edwin K Silverman,et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.
[14] J. Wedzicha,et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.
[15] E. Regan,et al. Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.
[16] J. Cooper,et al. National Emphysema Treatment Trial redux: accentuating the positive. , 2010, The Journal of thoracic and cardiovascular surgery.
[17] G. McLennan,et al. A randomized study of endobronchial valves for advanced emphysema. , 2010, The New England journal of medicine.
[18] N. Hopkinson,et al. Bronchoscopic lung volume reduction for emphysema: where next? , 2012, European Respiratory Journal.
[19] M. Noppen,et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort , 2012, European Respiratory Journal.
[20] F. Herth,et al. Segmental Approach to Lung Volume Reduction Therapy for Emphysema Patients , 2014, Respiration.
[21] F. Herth,et al. Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study , 2014, BMC Pulmonary Medicine.
[22] Endoscopic volume reduction in COPD- a critical review. , 2014, Deutsches Arzteblatt international.
[23] Emphysema: Imaging for Endoscopic Lung Volume Reduction. , 2015, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[24] R. Huebner,et al. Lung Volume Reduction in Pulmonary Emphysema from the Radiologist’s Perspective , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[25] Ipek Oguz,et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. , 2015, American journal of respiratory and critical care medicine.